Conditions: Ocular Inflammation Associated With Blepharaconjunctivitis
Keywords: Ocular inflammation blepharaconjunctivitis
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 221
Healthy volunteers: no

Brief summary:
The purpose of this study is to describe the differences in efficacy between TOBRADEX Ophthalmic Suspension and Tobramycin 0.3%/Dexamethasone 0.05% Ophthalmic Suspension in the treatment of ocular inflammation and infection associated with blepharaconjunctivitis

Detailed description:

Arms:
arm 1: Tobramycin 0.3%/Dexamethasone 0.05% 1 drop 4 times daily in both eyes arm 2: TOBRADEX 1 drop 4 times daily in both eyes

Interventions: intervention 1: Tobramycin 0.3%/Dexamethasone 0.05% intervention 2: TOBRADEX
Intervention descriptions: intervention 1: Tobramycin 0.3%/Dexamethasone 0.05% 1 drop in both eyes 4 times daily for at least 3 days intervention 2: TOBRADEX 1 drop in both eyes 4 times daily for at least 3 days

Protocol document: